ArticlePloS one2026
Optimization of extracellular vesicle extraction from hepatic tissue interstitial fluid and analysis of their ncRNA expression profiles.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo address the limited tissue specificity of extracellular vesicles (EVs) derived from blood and other body fluids, this study isolated small EVs (sEVs) from the tissue interstitial fluid (TIF) of hepatocellular carcinoma (HCC) and adjacent tissues. The expression profiles of non-coding RNAs (ncRNAs) were analyzed to identify more specific diagnostic biomarkers.
methodsAn optimized protocol for TIF-sEV extraction was established, which combined enzymatic digestion (Collagenase D and DNase I) with differential and ultracentrifugation. The isolated sEVs were characterized using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and western blotting (WB). The expression of 33 candidate ncRNAs (11 lncRNAs from TCGA-LIHC and 22 miRNAs from TCGA-LIHC and GSE302990) in TIF-sEVs was analyzed by qRT-PCR and integrated with clinical parameters via LASSO regression.
resultsThe optimal extraction conditions were determined to be digestion with Collagenase D (2 mg/mL) and DNase I (40 U/mL) for 30 minutes. The obtained EVs exhibited typical morphology, a particle size below 200 nm, and expressed canonical EV marker proteins (ALIX, CD63) as well as the hepatocyte-specific membrane protein ASGPR. qRT-PCR analysis revealed specific enrichment of six lncRNAs (e.g., AL031985, TMCC1-AS1) and eleven miRNAs (e.g., miR-1224-5p, miR-483-5p) in TIF-sEVs. LASSO regression applied to all 33 candidate ncRNAs and clinical parameters identified a combined diagnostic signature comprising ALB, PLT, DBIL, lncRNA GAS5, and miR-194-5p, which achieved an area under the curve (AUC) of 0.960.
conclusionsThis study establishes an efficient and stable system for the isolation and characterization of TIF-sEVs from liver tissue. Furthermore, it identifies multiple non-coding RNAs (ncRNAs) that are enriched in TIF-sEVs, thereby providing potential novel diagnostic biomarkers for the differential diagnosis and prognosis evaluation of HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.